"We are thrilled to expand our workforce in Dallas and San Diego," remarks Timothy J. Schroeder, Founder and CEO. "Both locations are rich with talent, and we look forward to the opportunities that will come from becoming a part of those communities. We have a very long history of successful collaborations in both areas with leading academic centers and emerging biotechnology companies and are excited to expand our team in both cities."
CTI, with an annual staff retention rate of 95%, has been working for two decades in the drug development industry across North America, Europe, South America, Pac-Asia, and Africa, specializing in clinical research programs involving critically ill patient populations, and has more than 30 offices worldwide to serve more than 200 pharmaceutical, biotechnology, and medical device clients. The company recently announced additional growth in the US in Raleigh, NC and San Francisco, CA.